Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Markers of inflammation and risk of coronary heart disease.
2009
Heparin-Protein Interactions
2002 Standout
Lp-PLA2- a novel risk factor for high-risk coronary and carotid artery disease
2010
Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials
2008
Triglycerides and Cardiovascular Disease
2011
Treatment of insulin resistance in diabetes mellitus
2004
The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role
2011 Standout
Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer
2018
Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention
2009
The metabolic syndrome
2010 Standout
The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease
2019
Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics
2004
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology
2004 Standout
Extracellular phospholipases in atherosclerosis
2010
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
2009
STREPTOCOCCUS BOVIS BACTERAEMIA: ITS SIGNIFICANCE FOR THE COLORECTAL SURGEON
1990
PRODUCTION OF CYTOKINES BY MONOCYTES, EPITHELIAL AND ENDOTHELIAL CELLS ACTIVATED BY STREPTOCOCCUS BOVIS
2000
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
HDL Cholesterol: Physiology, Pathophysiology, and Management
2007
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Inflammation and insulin resistance
2006 Standout
Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia
2006
Fetal lipoprotein changes in pre‐eclampsia
2008
Colorectal cancer
2019 Standout
Unusual Infections Associated with Colorectal Cancer
1988
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis)
2004
Inflammation and Colon Cancer
2010 Standout
The metabolic syndrome
2005 Standout
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
2006 Standout
ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
2014
Equine Metabolic Syndrome
2010 Standout
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
2005 Standout
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Serum cholesterol and ceruloplasmin levels in second trimester can predict development of pre-eclampsia
2013
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Apolipoprotein E and atherosclerosis: insight from animal and human studies
1999
Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention
2008
Management of metabolic syndrome: statins
2004
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials
2006
Prevalence of Liver Disease in Patients with Streptococcus bovis Bacteraemia
2001
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
2010 Standout
The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent
2008
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B–containing lipoproteins
2008 StandoutNobel
Evaluation of High-Sensitivity C-Reactive Protein and Serum Lipid Profile in Southeastern Nigerian Women with Pre-Eclampsia
2015 Standout
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
2005
Understanding the Role of ApoE Fragments in Alzheimer’s Disease
2018
Polycystic ovary syndrome
2016 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Down syndrome
2020 Standout
Plasticity and the Spread of Alzheimer's Disease-Like Changes
2003
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment
2015
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
<italic>Streptococcus bovis</italic> Bacteraemia Requires Rigorous Exclusion of Colonic Neoplasia and Endocarditis
1985
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
2005
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
2005
Effect of Rosiglitazone Treatment on Plaque Inflammation and Collagen Content in Nondiabetic Patients
2006
Markers of Inflammation and Risk of Coronary Heart Disease
2009
Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ
2012 Standout
Humoral Reactions in Human Endocarditis Due to Streptococcus bovis: Evidence for a Common S bovis Antigen
1983
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs
2009
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
2013
Recovery of uncommon bacteria from blood: association with neoplastic disease
1995
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
2005
Natural and Designed Proteins Inspired by Extremotolerant Organisms Can Form Condensates and Attenuate Apoptosis in Human Cells
2022 StandoutNobel
Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
2007
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review
2002
The Val279Phe Variant of the Lipoprotein-Associated Phospholipase A2 Gene Is Associated with Catalytic Activities and Cardiovascular Disease in Korean Men
2006
Clinical microbiology of coryneform bacteria
1997 Standout
Therapeutic Roles of Peroxisome Proliferator–Activated Receptor Agonists
2005
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
The Metabolic Syndrome
2008 Standout
Effects of apolipoprotein E (apoE) isoforms, β-amyloid (Aβ) and apoE/Aβ complexes on Protein Kinase C-α (PKC-α) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts
2001
Lipids and Lipoproteins in Patients With Type 2 Diabetes
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
2006
Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors
2005
Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome
2005
Is Treatment of Insulin Resistance Beneficial Independent of Glycemia?
2003
Differential Effect of Hypolipidemic Drugs on Lipoprotein-Associated Phospholipase A 2
2007
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
2013
Works of I. Friedrich being referenced
Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
1999
Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation
2000
Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes
2004
Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype
1996
Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action
2002
Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia
2003
Transient Remnant Removal Disease in Acute Fatty Liver of Pregnancy
2004
Lipoprotein-Associated Phospholipase A2 Predicts 5-Year Cardiac Mortality Independently of Established Risk Factors and Adds Prognostic Information in Patients with Low and Medium High-Sensitivity C-Reactive Protein (The Ludwigshafen Risk and Cardiovascular Health Study)
2007
Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus
2002
Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension
2003
The association of remote Streptococcus bovis bacteremia with colonic neoplasia.
1982